Trial intelligence / Profile preview

Propofol vs Sevoflurane in Brain Tumour Surgery

NCT02229201Phase 1Completed

Sponsor
University Medical Centre Ljubljana
Start
May 2010
Primary completion
Dec 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of propofol in brain tumor (2 arms), sponsored by University Medical Centre Ljubljana. Primary endpoint: Interleukin 10 plasma concentrations at 48 hours. Started May 2010; status: completed.

02

Drugs

propofol
03

Conditions

brain tumor

Beyond the preview

Go deeper on NCT02229201.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02229201.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call